Literature DB >> 10322021

Escherichia coli DNA topoisomerase I copurifies with Tn5 transposase, and Tn5 transposase inhibits topoisomerase I.

H Yigit1, W S Reznikoff.   

Abstract

Tn5 transposase (Tnp) overproduction is lethal to Escherichia coli. Genetic evidence suggested that this killing involves titration of E. coli topoisomerase I (Topo I). Here, we present biochemical evidence that supports this model. Tn5 Tnp copurifies with Topo I while nonkilling derivatives of Tnp, Delta37Tnp and Delta55Tnp (Inhibitor [Inh]), show reduced affinity or no affinity, respectively, for Topo I. In agreement with these results, the presence of Tnp, but not Delta37 or Inh derivatives of Tnp, inhibits the DNA relaxation activity of Topo I in vivo as well as in vitro. Other proteins, including RNA polymerase, are also found to copurify with Tnp. For RNA polymerase, reduced copurification with Tnp is observed in extracts from a topA mutant strain, suggesting that RNA polymerase interacts with Topo I and not Tnp.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10322021      PMCID: PMC93775     

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  26 in total

1.  Rifampin and rpoB mutations can alter DNA supercoiling in Escherichia coli.

Authors:  K Drlica; R J Franco; T R Steck
Journal:  J Bacteriol       Date:  1988-10       Impact factor: 3.490

2.  dnaA, an essential host gene, and Tn5 transposition.

Authors:  J C Yin; W S Reznikoff
Journal:  J Bacteriol       Date:  1987-10       Impact factor: 3.490

3.  Probing the structural domains and function in vivo of Escherichia coli DNA topoisomerase I by mutagenesis.

Authors:  L Zumstein; J C Wang
Journal:  J Mol Biol       Date:  1986-10-05       Impact factor: 5.469

4.  Measurement of enzyme activity.

Authors:  E F Rossomando
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

5.  Inhibition of bacterial segregation by early functions of phage mu and association of replication protein B with the inner cell membrane.

Authors:  C Boeckh; E G Bade; H Delius; J N Reeve
Journal:  Mol Gen Genet       Date:  1986-03

6.  Role of the IS50 R proteins in the promotion and control of Tn5 transposition.

Authors:  R C Johnson; W S Reznikoff
Journal:  J Mol Biol       Date:  1984-08-25       Impact factor: 5.469

7.  Regulation of the genes for E. coli DNA gyrase: homeostatic control of DNA supercoiling.

Authors:  R Menzel; M Gellert
Journal:  Cell       Date:  1983-08       Impact factor: 41.582

8.  Identification of a potent decatenating enzyme from Escherichia coli.

Authors:  R J DiGate; K J Marians
Journal:  J Biol Chem       Date:  1988-09-15       Impact factor: 5.157

9.  DNA gyrase is a host factor required for transposition of Tn5.

Authors:  R R Isberg; M Syvanen
Journal:  Cell       Date:  1982-08       Impact factor: 41.582

10.  Mutations in the gene coding for Escherichia coli DNA topoisomerase I affect transcription and transposition.

Authors:  R Sternglanz; S DiNardo; K A Voelkel; Y Nishimura; Y Hirota; K Becherer; L Zumstein; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

View more
  7 in total

1.  IS1397 is active for transposition into the chromosome of Escherichia coli K-12 and inserts specifically into palindromic units of bacterial interspersed mosaic elements.

Authors:  J M Clément; C Wilde; S Bachellier; P Lambert; M Hofnung
Journal:  J Bacteriol       Date:  1999-11       Impact factor: 3.490

2.  Small-Molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis Agents.

Authors:  Shayna Sandhaus; Thirunavukkarasu Annamalai; Greg Welmaker; Richard A Houghten; Carlos Paz; Pamela K Garcia; Angelo Andres; Gagandeep Narula; Carolina Rodrigues Felix; Sandra Geden; Mandy Netherton; Rashmi Gupta; Kyle H Rohde; Marc A Giulianotti; Yuk-Ching Tse-Dinh
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

3.  55.2, a phage T4 ORFan gene, encodes an inhibitor of Escherichia coli topoisomerase I and increases phage fitness.

Authors:  Yves Mattenberger; Filo Silva; Dominique Belin
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

Review 4.  Type IA Topoisomerases as Targets for Infectious Disease Treatments.

Authors:  Ahmed Seddek; Thirunavukkarasu Annamalai; Yuk-Ching Tse-Dinh
Journal:  Microorganisms       Date:  2021-01-01

Review 5.  Bacterial topoisomerase I as a target for discovery of antibacterial compounds.

Authors:  Yuk-Ching Tse-Dinh
Journal:  Nucleic Acids Res       Date:  2008-11-28       Impact factor: 16.971

6.  Roles of type 1A topoisomerases in genome maintenance in Escherichia coli.

Authors:  Valentine Usongo; Marc Drolet
Journal:  PLoS Genet       Date:  2014-08-07       Impact factor: 5.917

7.  An endogenous protein inhibitor, YjhX (TopAI), for topoisomerase I from Escherichia coli.

Authors:  Yoshihiro Yamaguchi; Masayori Inouye
Journal:  Nucleic Acids Res       Date:  2015-11-08       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.